Quarterly report pursuant to Section 13 or 15(d)

COMMITMENTS AND CONTINGENCIES - Patent Acquisition (Details Narrative)

v2.4.0.8
COMMITMENTS AND CONTINGENCIES - Patent Acquisition (Details Narrative) (USD $)
Jul. 31, 2013
May 21, 2013
Feb. 28, 2013
Exercise price of five year option      
Acquisition of four patents cash, purchase price     $ 1,000,000
Acquisition of four patents, common stock issued     403,226
Obligated to pay Dr Cox, net proceeds percentage     12.50%
Cash consideration for patent acquisition (Mirror Worlds)   $ 3,000,000  
Issued 5-year warrants to purchase an aggregate shares of common stock   2,250,000  
60 days Warrants to purchase shares of common stock   500,000  
Additional 5-year warrants to purchase shares of common stock as a result of exercise of 60-day warrant 250,000    
Net proceeds percentage payable to third party from the monetization of the Mirror Worlds patent portfolio      
First $125 Million   10.00%  
Next $125 Million   15.00%  
Over $250 Million   20.00%